{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T17:43:47Z","timestamp":1782755027060,"version":"3.54.5"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IJID Regions"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ijregi.2026.100908","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T16:15:45Z","timestamp":1777306545000},"page":"100908","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Characterizing isoniazid preventive therapy uptake among people living with human immunodeficiency virus in Tanzania, a resource-constrained setting with a high tuberculosis burden: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4640-5559","authenticated-orcid":false,"given":"Emmanuel M.","family":"Sindato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6122-3828","authenticated-orcid":false,"given":"Violet Dismas","family":"Kajogoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel Jackob","family":"Mchonde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonaventura C.T.","family":"Mpondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijregi.2026.100908_bib0001","article-title":"Isoniazid preventive therapy in HIV-infected pregnant and postpartum women in high prevalence of tuberculosis countries: a protocol for systematic review","volume":"99","author":"Wang","year":"2020","journal-title":"Medicine"},{"key":"10.1016\/j.ijregi.2026.100908_bib0002","doi-asserted-by":"crossref","first-page":"e1646","DOI":"10.1016\/S2214-109X(22)00372-2","article-title":"Re-evaluating the health impact and cost-effectiveness of tuberculosis preventive treatment for modern HIV cohorts on antiretroviral therapy: a modelling analysis using data from Tanzania","volume":"10","author":"Zhu","year":"2022","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.ijregi.2026.100908_bib0003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jia2.25438","article-title":"New opportunities in tuberculosis prevention: implications for people living with HIV","volume":"23","author":"Gonz\u00e1lez Fern\u00e1ndez","year":"2020","journal-title":"J Intern AIDS Soc"},{"key":"10.1016\/j.ijregi.2026.100908_bib0004","doi-asserted-by":"crossref","first-page":"219","DOI":"10.15562\/bmj.v9i1.1684","article-title":"Effect of isoniazid preventive therapy on pulmonary tuberculosis activity in people living with HIV\/AIDS at wangaya hospital in Denpasar, Bali, Indonesia: a prospective cohort study","volume":"9","author":"Suryana","year":"2020","journal-title":"Bali Med J"},{"key":"10.1016\/j.ijregi.2026.100908_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-022-07867-5","article-title":"Assessment of contextual factors shaping delivery and uptake of isoniazid preventive therapy among people living with HIV in Dar es Salaam, Tanzania","volume":"22","author":"Nyarubamba","year":"2022","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijregi.2026.100908_bib0006","doi-asserted-by":"crossref","first-page":"29","DOI":"10.24248\/eahrj.v2i1.564","article-title":"Tuberculosis contact screening and isoniazid preventive therapy among children under 5 in the Mbeya and Songwe regions","volume":"2","author":"Mwasubila","year":"2018","journal-title":"Tanzania. East Afr Health Res J"},{"key":"10.1016\/j.ijregi.2026.100908_bib0007","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12982-024-00139-4","article-title":"Knowledge, attitude and practice of healthcare workers on isoniazid preventive treatment in Tanzania; a health facility-based cross-sectional study","volume":"21","author":"Mshiu","year":"2024","journal-title":"Discov Public Health"},{"key":"10.1016\/j.ijregi.2026.100908_bib0008","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"European","year":"2010","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.ijregi.2026.100908_bib0009","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.5588\/ijtld.10.0788","article-title":"Completion of isoniazid preventive therapy and survival in HIV-infected, TST-positive adults in Tanzania","volume":"15","author":"Kabali","year":"2011","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ijregi.2026.100908_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-015-1085-7","article-title":"Acceptability and adherence to isoniazid preventive therapy in HIV-infected patients clinically screened for latent tuberculosis in Dar es Salaam, Tanzania","volume":"15","author":"Shayo","year":"2015","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijregi.2026.100908_bib0011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-019-3696-x","article-title":"Effect of isoniazid preventive therapy on tuberculosis incidence and associated risk factors among HIV infected adults in Tanzania: a retrospective cohort study","volume":"19","author":"Sabasaba","year":"2019","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijregi.2026.100908_bib0012","first-page":"1","article-title":"Correction to: successful implementation of isoniazid preventive therapy at a pediatric HIV clinic in Tanzania","volume":"20","author":"Hunter","year":"2020","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijregi.2026.100908_bib0013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.11604\/pamj.2021.38.197.26752","article-title":"Facility and patient barriers in the implementation of isoniazid preventive therapy for people living with HIV attending care and treatment centers, Songea municipality, Tanzania","volume":"38","author":"Komba","year":"2021","journal-title":"Pan Afr Med J"},{"key":"10.1016\/j.ijregi.2026.100908_bib0014","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.ijid.2020.11.192","article-title":"Coverage of isoniazid preventive therapy among people living with HIV; A retrospective cohort study in Tanzania (2012\u20132016)","volume":"103","author":"Maokola","year":"2021","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ijregi.2026.100908_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-020-04997-6","article-title":"Determinants of isoniazid preventive therapy completion among people living with HIV attending care and treatment clinics from 2013 to 2017 in Dar es Salaam Region, Tanzania. a cross-sectional analytical study","volume":"20","author":"Robert","year":"2020","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijregi.2026.100908_bib0016","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0254082","article-title":"Impact of isoniazid Preventive Therapy on tuberculosis incidence among people living with HIV: A secondary data analysis using Inverse Probability Weighting of individuals attending HIV care and treatment clinics in Tanzania","volume":"16","author":"Maokola","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.ijregi.2026.100908_bib0017","doi-asserted-by":"crossref","first-page":"141","DOI":"10.5588\/pha.22.0018","article-title":"IPT coverage and determinants of care coverage in Tanzania","volume":"12","author":"Manisha","year":"2022","journal-title":"Public Health Action"},{"key":"10.1016\/j.ijregi.2026.100908_bib0018","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ijtb.2023.07.005","article-title":"Isoniazid preventive therapy among HIV infected patients on antiretroviral therapy diagnosed with latent tuberculosis: a retrospective assessment of the outcome in Tanzania","volume":"72","author":"J Marwa","year":"2025","journal-title":"Indian J Tuberc"},{"key":"10.1016\/j.ijregi.2026.100908_bib0019","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4236\/wja.2020.102009","article-title":"Initiation of isoniazid prophylactic therapy among newly diagnosed HIV-positive persons in three high HIV-burden districts of South Africa","volume":"10","author":"Fomundam","year":"2020","journal-title":"World J AIDS"},{"key":"10.1016\/j.ijregi.2026.100908_bib0020","doi-asserted-by":"crossref","first-page":"57","DOI":"10.4103\/njbcs.njbcs_9_19","article-title":"Uptake of isoniazid preventive therapy for tuberculosis among HIV patients in Kano","volume":"17","author":"Jalo","year":"2020","journal-title":"Nigeria. Niger J Basic Clin Sci"},{"key":"10.1016\/j.ijregi.2026.100908_bib0021","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0234588","article-title":"Outcomes of isoniazid preventive therapy among people living with HIV in Kenya: a retrospective study of routine health care data","volume":"15","author":"Karanja","year":"2020","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.ijregi.2026.100908_bib0022","first-page":"86","article-title":"WHO consolidated guidelines on tuberculosis. Module 1: prevention: tuberculosis preventive treatment","year":"2021","journal-title":"Tuberc Lung Dis HIV Infect"},{"key":"10.1016\/j.ijregi.2026.100908_bib0023","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s40265-024-02131-3","article-title":"Tuberculosis preventive treatment in high TB-burden settings: a state-of-the-art review","volume":"85","author":"Chihota","year":"2024","journal-title":"Drugs"},{"key":"10.1016\/j.ijregi.2026.100908_bib0024","doi-asserted-by":"crossref","first-page":"e1205","DOI":"10.1016\/S2214-109X(23)00251-6","article-title":"Impact and cost-effectiveness of short-course tuberculosis preventive treatment for household contacts and people with HIV in 29 high-incidence countries: a modelling analysis","volume":"11","author":"Ryckman","year":"2023","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.ijregi.2026.100908_bib0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgph.0003142","article-title":"Optimizing delivery strategies for 3HP tuberculosis preventive treatment in Tanzania: a qualitative study on acceptability of family approach in HIV care and treatment centres","volume":"4","author":"Pamba","year":"2024","journal-title":"PLoS Glob Public Health"},{"key":"10.1016\/j.ijregi.2026.100908_bib0026","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1005136","article-title":"New regimens to prevent tuberculosis in adults with HIV infection","volume":"365","author":"Martinson","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijregi.2026.100908_bib0027","first-page":"1","article-title":"Prevalence and associated factors of tuberculosis among isoniazid users and non-users of HIV patients in Dessie","volume":"12","author":"Mebratu","year":"2022","journal-title":"Ethiopia. Sci Rep"},{"key":"10.1016\/j.ijregi.2026.100908_bib0028","doi-asserted-by":"crossref","first-page":"621","DOI":"10.3390\/ijerph20010621","article-title":"Isoniazid preventive therapy for prevention of tuberculosis among people living with HIV in Ethiopia: a systematic review of implementation and impacts","volume":"20","author":"Assefa","year":"2023","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.ijregi.2026.100908_bib0029","first-page":"367","article-title":"Assessment of tuberculosis intensified case finding and isoniazid preventive therapy for people living with hiv in enugu state, nigeria","volume":"23","author":"Igbokwe","year":"2020","journal-title":"Afr J Biomed Res"},{"key":"10.1016\/j.ijregi.2026.100908_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2020\/7025738","article-title":"Does isoniazid preventive therapy provide better treatment outcomes in HIV-infected individuals in Northern Ethiopia? A retrospective cohort study","volume":"2020","author":"Atey","year":"2020","journal-title":"AIDS Res Treat"},{"key":"10.1016\/j.ijregi.2026.100908_bib0031","first-page":"127","article-title":"Assessment of isoniazid preventive therapy outcome among people living with HIV in a referral hospital","volume":"9","author":"Mengesha","year":"2020","journal-title":"Northeast Ethiopia. Integr Pharm Res Pract"},{"key":"10.1016\/j.ijregi.2026.100908_bib0032","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s40794-020-00106-2","article-title":"Utilization of isoniazid prophylaxis therapy and its associated factors among HIV positive clients taking antiretroviral therapy at Fre Semaetat primary hospital, Hawzien districts, Tigrai, Northern Ethiopia","volume":"6","author":"Legese","year":"2020","journal-title":"Trop Dis Travel Med Vaccin"},{"key":"10.1016\/j.ijregi.2026.100908_bib0033","doi-asserted-by":"crossref","first-page":"e3555","DOI":"10.1093\/cid\/ciaa1083","article-title":"Effects of pregnancy and isoniazid preventive therapy on Mycobacterium tuberculosis interferon gamma response assays in women with HIV","volume":"73","author":"Weinberg","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijregi.2026.100908_bib0034","first-page":"1","article-title":"Cost-Effectiveness of isoniazid preventive therapy among HIV-infected patients clinically screened for latent tuberculosis infection in Dar es Salaam, Tanzania: a prospective cohort study","volume":"18","author":"Shayo","year":"2017","journal-title":"BMC Public Health"},{"key":"10.1016\/j.ijregi.2026.100908_bib0035","first-page":"23","article-title":"Determinants of isoniazid preventive therapy completion among people living with HIV in Oyo and Ogun states, Southwest Nigeria","volume":"34","author":"Olajide","year":"2022","journal-title":"J Community Med Prim Health Care"},{"key":"10.1016\/j.ijregi.2026.100908_bib0036","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1080\/09540121.2019.1619661","article-title":"Predictors of isoniazid preventive therapy completion among HIV-infected patients receiving differentiated and non-differentiated HIV care in rural Uganda","volume":"32","author":"Tram","year":"2020","journal-title":"AIDS Care"},{"key":"10.1016\/j.ijregi.2026.100908_bib0037","doi-asserted-by":"crossref","first-page":"1","DOI":"10.11604\/pamj.2020.36.261.22496","article-title":"Knowledge and adherence to isoniazid preventive therapy among people living with HIV (PLHIV) in multilevel health facilities in south-east, Nigeria: baseline findings from a quasi-experimental study","volume":"36","author":"Akamike","year":"2020","journal-title":"Pan Afr Med J"}],"container-title":["IJID Regions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772707626000718?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772707626000718?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T16:44:01Z","timestamp":1782751441000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772707626000718"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":37,"alternative-id":["S2772707626000718"],"URL":"https:\/\/doi.org\/10.1016\/j.ijregi.2026.100908","relation":{},"ISSN":["2772-7076"],"issn-type":[{"value":"2772-7076","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterizing isoniazid preventive therapy uptake among people living with human immunodeficiency virus in Tanzania, a resource-constrained setting with a high tuberculosis burden: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"IJID Regions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijregi.2026.100908","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"100908"}}